Rhythm Biosciences Retains fifth consecutive ISO certification for ColoSTAT
- Rhythm Biosciences (RHY) retains its ISO certification for a fifth consecutive year
- The certification means Rhythm has met the international standard for in-vitro diagnostics and medical devices for its ColoSTAT blood test product
- ISO 13485:2016 is the internationally-recognised quality standard to ensure the consistent design, manufacture, and sale of medical devices that are safe for their intended purposes
- The certification was conducted by the British Standards Institution
- Rhythm says the ISO certification is a “critical component” of its commercial and market entry strategies and validates the company’s quality management systems to deliver its cancer detection technology
- RhythmBiosciences is up 0.53 per cent and trading at 95.5 cents at 3:58 pm AEDT
